Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids

Project Information

RESIST3D

Grant agreement ID: 845045

DOI 10.3030/845045

Project closed

EC signature date 18 March 2019

Start date 1 September 2020

End date 31 August 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 207 312,00

EU contribution € 207 312,00

Coordinated by

KOBENHAVNS UNIVERSITET
Denmark